EE200300491A - 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena - Google Patents
6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritenaInfo
- Publication number
- EE200300491A EE200300491A EEP200300491A EEP200300491A EE200300491A EE 200300491 A EE200300491 A EE 200300491A EE P200300491 A EEP200300491 A EE P200300491A EE P200300491 A EEP200300491 A EE P200300491A EE 200300491 A EE200300491 A EE 200300491A
- Authority
- EE
- Estonia
- Prior art keywords
- kinase inhibitors
- substituted indolinones
- indolinones
- substituted
- kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10117204A DE10117204A1 (de) | 2001-04-06 | 2001-04-06 | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
PCT/EP2002/003583 WO2002081445A1 (de) | 2001-04-06 | 2002-03-30 | In 6-stellung substituierte indoline und ihre verwendung als kinase-inhibitoren |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300491A true EE200300491A (et) | 2004-02-16 |
Family
ID=7680648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300491A EE200300491A (et) | 2001-04-06 | 2002-03-30 | 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena |
Country Status (23)
Country | Link |
---|---|
US (1) | US6858641B2 (de) |
EP (1) | EP1379501A1 (de) |
JP (1) | JP2004525173A (de) |
KR (1) | KR20030090712A (de) |
CN (1) | CN1509270A (de) |
AR (1) | AR035813A1 (de) |
BG (1) | BG108220A (de) |
BR (1) | BR0208900A (de) |
CA (1) | CA2442695A1 (de) |
CZ (1) | CZ20032975A3 (de) |
DE (1) | DE10117204A1 (de) |
EA (1) | EA200301005A1 (de) |
EC (1) | ECSP034776A (de) |
EE (1) | EE200300491A (de) |
HU (1) | HUP0303737A3 (de) |
IL (1) | IL158254A0 (de) |
MX (1) | MXPA03008896A (de) |
NO (1) | NO20034434L (de) |
PE (1) | PE20021058A1 (de) |
PL (1) | PL366458A1 (de) |
SK (1) | SK12412003A3 (de) |
WO (1) | WO2002081445A1 (de) |
ZA (1) | ZA200307306B (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10233500A1 (de) * | 2002-07-24 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel |
US7148249B2 (en) * | 2002-09-12 | 2006-12-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments |
JP4879492B2 (ja) * | 2002-11-27 | 2012-02-22 | アラーガン、インコーポレイテッド | 疾患の治療のためのキナーゼ阻害剤 |
US20060154939A1 (en) * | 2004-12-24 | 2006-07-13 | Boehringer Ingelheim International Gmbh | Medicaments for the Treatment or Prevention of Fibrotic Diseases |
PE20061155A1 (es) * | 2004-12-24 | 2006-12-16 | Boehringer Ingelheim Int | Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
WO2007057397A1 (en) * | 2005-11-15 | 2007-05-24 | Boehringer Ingelheim International Gmbh | Treatment of cancer |
NZ584454A (en) | 2007-10-12 | 2011-09-30 | Ingenium Pharmaceuticals Gmbh | N-[6-phenyl-pyrimidin-4-yl]-amides and urea derivatives as inhibitors of protein kinases |
PE20091445A1 (es) * | 2007-12-03 | 2009-10-19 | Boehringer Ingelheim Int | Derivados de indolinona y procedimiento para su fabricacion |
US20170065529A1 (en) | 2015-09-09 | 2017-03-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical dosage form for immediate release of an indolinone derivative |
WO2010009166A1 (en) * | 2008-07-14 | 2010-01-21 | Gilead Colorado, Inc. | Oxindolyl inhibitor compounds |
PE20110213A1 (es) * | 2008-07-29 | 2011-04-16 | Boehringer Ingelheim Int | Derivados de indolinona como inhibidores de quinasa |
CN102834380B (zh) | 2010-03-10 | 2015-04-01 | 阿斯利康公司 | 蛋白激酶的抑制剂 |
CN102267934B (zh) * | 2010-06-02 | 2013-04-17 | 金凯美(大连)医药科技有限公司 | 一种6-甲氧羰基吲哚酮的制备方法 |
EP3722291B1 (de) * | 2015-12-24 | 2023-07-19 | Respivert Limited | Indolinon-verbindungen und deren verwendung zur behandlung von fibrotischen krankheiten |
JP7039480B2 (ja) * | 2016-03-08 | 2022-03-22 | レスピバート・リミテツド | プロテインキナーゼ阻害剤としてのインドール誘導体およびそれらの使用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2251741T3 (es) * | 1996-08-23 | 2006-05-01 | Sugen, Inc. | Bibliotecas combinatorias de indolinona y productos afines y metodos para el tratamiento de enfermedades. |
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
US6043254A (en) * | 1998-04-03 | 2000-03-28 | Boehringer Ingelheim Pharma Kg | Indolinones having kinase-inhibiting activity |
DE19816624A1 (de) | 1998-04-15 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
US6169106B1 (en) * | 1998-04-15 | 2001-01-02 | Boehringer Ingelheim Pharma Kg | Indolinones having kinase inhibitory activity |
DE19824922A1 (de) | 1998-06-04 | 1999-12-09 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
US6319918B1 (en) * | 1998-06-04 | 2001-11-20 | Boehringer Ingelheim Pharma Kg | Substituted indolinones with kinase inhibitory activity |
DE19924401A1 (de) | 1999-05-27 | 2000-11-30 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
EP1212318B1 (de) | 1999-08-27 | 2006-01-25 | Boehringer Ingelheim Pharma GmbH & Co.KG | Substituierte indolinone als tyrosinkinase inhibitoren |
DE19940829A1 (de) | 1999-08-27 | 2001-03-01 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
UA75054C2 (uk) | 1999-10-13 | 2006-03-15 | Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг | Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу |
DE10042696A1 (de) | 2000-08-31 | 2002-03-14 | Boehringer Ingelheim Pharma | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
-
2001
- 2001-04-06 DE DE10117204A patent/DE10117204A1/de not_active Withdrawn
-
2002
- 2002-03-30 WO PCT/EP2002/003583 patent/WO2002081445A1/de not_active Application Discontinuation
- 2002-03-30 CZ CZ20032975A patent/CZ20032975A3/cs unknown
- 2002-03-30 HU HU0303737A patent/HUP0303737A3/hu unknown
- 2002-03-30 CA CA002442695A patent/CA2442695A1/en not_active Abandoned
- 2002-03-30 IL IL15825402A patent/IL158254A0/xx unknown
- 2002-03-30 EE EEP200300491A patent/EE200300491A/xx unknown
- 2002-03-30 JP JP2002579433A patent/JP2004525173A/ja not_active Ceased
- 2002-03-30 BR BR0208900-9A patent/BR0208900A/pt active Pending
- 2002-03-30 SK SK1241-2003A patent/SK12412003A3/sk unknown
- 2002-03-30 CN CNA028099184A patent/CN1509270A/zh active Pending
- 2002-03-30 MX MXPA03008896A patent/MXPA03008896A/es unknown
- 2002-03-30 EA EA200301005A patent/EA200301005A1/ru unknown
- 2002-03-30 PL PL02366458A patent/PL366458A1/xx not_active Application Discontinuation
- 2002-03-30 KR KR10-2003-7013027A patent/KR20030090712A/ko not_active Application Discontinuation
- 2002-03-30 EP EP02735201A patent/EP1379501A1/de not_active Withdrawn
- 2002-04-04 US US10/116,365 patent/US6858641B2/en not_active Expired - Lifetime
- 2002-04-05 PE PE2002000279A patent/PE20021058A1/es not_active Application Discontinuation
- 2002-04-05 AR ARP020101257A patent/AR035813A1/es not_active Withdrawn
-
2003
- 2003-09-18 ZA ZA200307306A patent/ZA200307306B/xx unknown
- 2003-09-24 EC EC2003004776A patent/ECSP034776A/es unknown
- 2003-10-01 BG BG108220A patent/BG108220A/bg active Pending
- 2003-10-03 NO NO20034434A patent/NO20034434L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL366458A1 (en) | 2005-02-07 |
EP1379501A1 (de) | 2004-01-14 |
EA200301005A1 (ru) | 2004-04-29 |
WO2002081445A1 (de) | 2002-10-17 |
ECSP034776A (es) | 2003-12-01 |
CZ20032975A3 (cs) | 2004-02-18 |
SK12412003A3 (sk) | 2004-04-06 |
KR20030090712A (ko) | 2003-11-28 |
US6858641B2 (en) | 2005-02-22 |
ZA200307306B (en) | 2004-08-31 |
IL158254A0 (en) | 2004-05-12 |
PE20021058A1 (es) | 2003-01-20 |
NO20034434D0 (no) | 2003-10-03 |
CN1509270A (zh) | 2004-06-30 |
BG108220A (bg) | 2004-09-30 |
US20030092756A1 (en) | 2003-05-15 |
HUP0303737A3 (en) | 2004-09-28 |
NO20034434L (no) | 2003-10-03 |
BR0208900A (pt) | 2004-04-20 |
MXPA03008896A (es) | 2003-12-08 |
HUP0303737A2 (hu) | 2004-03-01 |
JP2004525173A (ja) | 2004-08-19 |
DE10117204A1 (de) | 2002-10-10 |
AR035813A1 (es) | 2004-07-14 |
CA2442695A1 (en) | 2002-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200200715A (et) | Asendatud kinasoliini derivaadid ja nende kasutamine inhibiitoritena | |
DE60208661D1 (de) | Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren | |
EE200300459A (et) | Uued spirotritsüklilised derivaadid ja nende kasutamine fosfodiesteraas-7 inhibiitoritena | |
DE60103974D1 (de) | Gyrase-inhibitoren und ihre verwendung | |
IS6968A (is) | Nýir týrósínkínasa tálmar | |
DK1419152T3 (da) | HIV-hæmmende pyrimidin-derivater | |
ATE505471T1 (de) | Azaindol-kinaseinhibitoren | |
EE200300085A (et) | Pürasooli derivaadid ja nende kasutamine proteiini kinaasi inhibiitoritena | |
ATE446093T1 (de) | Substituierte chinazolin-derivate als aurora- kinase inhibitoren | |
DK1650203T3 (da) | Quinolinonderivater som tyrosinkinaseinhibitorer | |
IL161516A0 (en) | Benzimidazoles useful as protein kinase inhibitors | |
IS7700A (is) | Ný spíróþétt kínasólínón og notkun þeirra sem fosfórdíesterasa hindrar | |
IS6524A (is) | 5-alkýlpyrídó(3-3-D)pyrimídín týrósín kínasa tálmar | |
NO20021820D0 (no) | Tyrosinkinaseinhibitorer | |
DE60328735D1 (de) | Chinazolinderivate | |
DK1361880T3 (da) | 6-substituerede pyrido-pyrimidiner | |
EE200300491A (et) | 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena | |
NO20042742L (no) | Pyrimidinforbindelser | |
NO20043580L (no) | Quinazolinonderivater og deres bruk som CB agonister | |
DE50206094D1 (de) | Substituierte isoindole und ihre verwendung | |
NO20040175L (no) | Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler | |
DE50202730D1 (de) | Substituierte isoindole und ihre verwendung | |
NO20041938L (no) | Anvendelse av fosfodiesterase IV-inhibitorer | |
DE60215804D1 (de) | 4-aminopyrimidine derivate | |
ATE299873T1 (de) | Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate |